JPRN-UMIN000018407
Completed
未知
The effect of vascular endothelial growth factor taking tube shunt for neovascular glaucoma - The effect of VEGF taking tube shunt for NVG
Yokohama City university center hospital the department of opthalmology0 sites20 target enrollmentJuly 25, 2015
Conditionsneovascular glaucoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- neovascular glaucoma
- Sponsor
- Yokohama City university center hospital the department of opthalmology
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •S.L(\-) The past history of any glaucoma operation The past history of any glaucoma except NVG The past history of anti VEGF therapy within one month The past history of constitutional symptom
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of anti-vascular endothelial growth factor (VEGF) drugs in chronic central serous chorioretinopathy (CSC)chronic central serous chorioretinopathyJPRN-UMIN000014110Kansai medical university takii hospital10
Recruiting
Not Applicable
Association of Vascular Endothelial Growth Factor (VEGF) serum levels And Ankylosing Spondylitis in Egyptian patientsAnkylosing spondylitisPACTR202210522771809Hossam salaheldin Abdelmohsen Labib70
Recruiting
Not Applicable
Vascular Endothelial Growth Factor, thrombelastography and coagulation in the context of etiology, outcome and clinical course of patients after circulatory arrestI46Cardiac arrestDRKS00033234BG-Klinikum Unfallkrankenhaus Berlin150
Recruiting
Phase 3
A clinical trial to study the levels of vascular endothelial growth factor in the fluid in the front part of the eye in cases of occlusion of venous supply of the eye and to correlate with the clinical features and nerve thickness as obtained by scanning and nerve function testsCTRI/2012/12/003270arayana Nethralaya30
Completed
Not Applicable
Anti-vascular endothelial growth factor therapy for ocular diseases of neovascularizatioretinopathy of prematurity neovascular glaucome vasoproliferative tumor choroidal neovascularizationJPRN-UMIN000027243School of Medicine Toho University20